Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hongyuan Zhou
Institution:
Xuzhou Medical College
Observed institution:
Xuzhou Medical College
ORCID:
0009-0001-0809-1950
Observed ORCID:
0009-0001-0809-1950
OpenAlex ID:
A5140550565
Data from Long-term Follow-up of Third-generation Anti-CD30 CAR T-cell Therapy in Relapsed/Refractory CD30+ Lymphomas: A Single-Arm, Multicenter, Phase I/II Trial
2026
·
Xiangmin Wang
, Qing Zhang
, et al.
Supplementary Data 1 from Long-term Follow-up of Third-generation Anti-CD30 CAR T-cell Therapy in Relapsed/Refractory CD30+ Lymphomas: A Single-Arm, Multicenter, Phase I/II Trial
2026
·
Xiangmin Wang
, Qing Zhang
, et al.
Long-term Follow-up of Third-generation Anti-CD30 CAR T-cell Therapy in Relapsed/Refractory CD30+ Lymphomas: A Single-Arm, Multicenter, Phase I/II Trial
2026
·
Xiangmin Wang
, Qing Zhang
, et al.
·
Clinical Cancer Research
Long-term follow-up of third generation anti-CD30 CAR T-cell therapy in relapsed/refractory CD30+ lymphomas: a single-arm, multicentre, phase 1-2 trial
2026
·
Affiliated Hospital of Xuzhou Medical University
, Xiangmin Wang
, et al.
·
Vivli
Show more works
View as search
Works count:
4
Citation count:
H-index:
I10-index:
Year
Topic
Type